|1.||O'Neill, Peter: 1 article (05/2013)|
|2.||Folkes, Lisa K: 1 article (05/2013)|
|3.||Denofrio, M Paula: 1 article (11/2009)|
|4.||Thomas, Andrés H: 1 article (11/2009)|
|5.||Cabrerizo, Franco M: 1 article (11/2009)|
|6.||Hatz, Sonja: 1 article (11/2009)|
|7.||Lorente, Carolina: 1 article (11/2009)|
|8.||Ogilby, Peter R: 1 article (11/2009)|
|9.||Caillat, Christophe: 1 article (10/2009)|
|10.||Agrofoglio, Luigi André: 1 article (10/2009)|
04/01/2007 - "Reactivity to dGMP in the cell-free system correlates with cytotoxicity in two of four human cancer cell lines as determined by means of the MTT assay. "
04/28/2002 - "Study on the amount of binding of anti-tumor metal complexes to different target sites of dGMP using trans-[en(2)Os(eta2-H(2))(CF(3)SO(3))](CF(3)SO(3)) in a competitive mode."
04/28/2002 - "The minimum percentages of binding of anti-tumor metal complexes to different sites of dGMP were also determined."
11/01/1999 - "administration of the mentioned ACNs in the same dose a reduction of tumor mass is accompanied by the inhibition of dAMP, dGMP and dTMP synthesis. "
11/01/2009 - "To further assess the photosensitizing capability of lumazine (Lum) experiments were performed using the nucleotide 2'-deoxyguanosine 5'-monophosphate (dGMP) and, independently, cervical cancer cells (HeLa cell line) as targets. "
|2.||Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/10/2005 - "When the pH of the DNA solution buffer increased from 3 to 11, the A260/A280 ratio changed significantly from 1.5 to 2.2 in mixtures of DNA bases [A:T:C:G = 28.5:28.5: 21.5:21.5, i.e., (A + T)/(all four bases) = 57%, expressed as mole percent], of deoxyribonucleosides (adenosine:thymidine:cytidine:guanosine= 28.5:28.5:21.5:21.5, as mole percent), or of deoxyribonucleotides (dAMP:dTMP:dGMP:dCMP = 28.5:28.5:21.5:21.5, as mole percent) examined. "
|3.||Genetic Predisposition to Disease (Genetic Predisposition)
06/21/1995 - "Using DNA-adduct detection methods specific for 7-methyl-dGMP and PAH-dGMP, we sought to determine whether an inherited genetic susceptibility to cancer associated with certain carcinogen-metabolizing and detoxifying genes (e.g., cytochrome P450 and glutathione S-transferase) is related to DNA adduct formation in lung tissue. "
01/01/2003 - "1-(4-chlorophenyl)-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline (3), 1-(2,3-dichlorophenyl)-6,7-dihydroxy 1,2,3,4-tetrahydroisoquinoline (4) and 1-(3-methoxyphenyl)-6,7-dihydroxy 1,2,3,4-tetrahydroisoquinoline (5) at 0.2 mM concentration caused a mixed type inhibition of the synthesis of dTMP and dGMP by, on average, 33.2+/-4.4%, and reduced the content of dTTP and dGTP in the acid soluble fraction (52.6+/-3.7% of control) but were active only in the cytosol of neurofibrosarcoma. "
|2.||Thymidine Monophosphate (TMP)
|3.||DNA (Deoxyribonucleic Acid)
|4.||2'-deoxyguanosine 5'-phosphate (dGMP)
|8.||Hepatitis B Surface Antigens (HBsAg)
|9.||5'-Guanylic Acid (GMP)